Champions Oncology (CSBR) Reports Q4 Loss of $0.15/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Champions Oncology (CSBR) Reports Q4 Loss of $0.15/Share

Champions Oncology Reports 38% Revenue Growth for Fiscal Year Ended April 30, 2017

July 27, 2017 4:01 PM EDT

HACKENSACK, N.J., July 27, 2017 /PRNewswire/ -- Champions Oncology, Inc. (Nasdaq: CSBR), engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, today announced its financial results for the fourth quarter and year ended April 30, 2017.

Fourth Quarter and Recent Business Highlights:

Record annual revenue of $15.4M, a 38% year over year increase Record TOS segment revenue of $13.7M, a 49% year-over-year increase Record annual TOS bookings, a 51% year over year increase Opened new lab facility in Rockville, Maryland, doubling... More